• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棒酸及其他抑制剂对卡他莫拉菌β-内酰胺酶的抑制作用。

Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.

作者信息

Farmer T, Reading C

出版信息

Drugs. 1986;31 Suppl 3:70-8. doi: 10.2165/00003495-198600313-00015.

DOI:10.2165/00003495-198600313-00015
PMID:3488199
Abstract

The beta-lactamases of Branhamella catarrhalis Ravasio and strain 1908 were readily inhibited by low concentrations of sulbactam, beta-halopenicillanic acids, MM 13902 and clavulanic acid. More detailed studies on the interaction of the Ravasio beta-lactamase with clavulanic acid demonstrated that the enzyme had high affinity for the inhibitor (Ki = 0.07 mumol/L) and was rapidly inhibited (t1/2 = 21 sec, kinhib. = 0.033/sec). Two types of enzyme-inhibitor complex were formed, a transiently stable species (t1/2 = 5.3 minutes at pH 7.3 and 37 degrees C) and a more stable species (t1/2 approximately equal to 2 hours at pH 7.3 and 37 degrees C). Irreversible inactivation of the enzyme was not achieved. Permeability studies on whole cells showed that beta-lactam antibiotics and beta-lactamase inhibitors readily penetrated the outer membrane of B. catarrhalis.

摘要

卡他布兰汉菌拉瓦西菌株和1908菌株的β-内酰胺酶很容易被低浓度的舒巴坦、β-卤代青霉烷酸、MM 13902和克拉维酸抑制。对拉瓦西β-内酰胺酶与克拉维酸相互作用的更详细研究表明,该酶对抑制剂具有高亲和力(Ki = 0.07 μmol/L),并且被迅速抑制(t1/2 = 21秒,kinhib. = 0.033/秒)。形成了两种类型的酶-抑制剂复合物,一种是短暂稳定的物种(在pH 7.3和37℃下t1/2 = 5.3分钟)和一种更稳定的物种(在pH 7.3和37℃下t1/2约等于2小时)。未实现酶的不可逆失活。对全细胞的通透性研究表明,β-内酰胺抗生素和β-内酰胺酶抑制剂很容易穿透卡他布兰汉菌的外膜。

相似文献

1
Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.棒酸及其他抑制剂对卡他莫拉菌β-内酰胺酶的抑制作用。
Drugs. 1986;31 Suppl 3:70-8. doi: 10.2165/00003495-198600313-00015.
2
Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.卡他布兰汉菌β-内酰胺酶的检测、分布及抑制作用
Drugs. 1986;31 Suppl 3:64-9. doi: 10.2165/00003495-198600313-00014.
3
Inhibition of beta-lactamases in Branhamella catarrhalis.卡他布兰汉菌中β-内酰胺酶的抑制作用。
Drugs. 1986;31 Suppl 3:79-81. doi: 10.2165/00003495-198600313-00016.
4
Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
J Chemother. 1994 Dec;6(6):383-7. doi: 10.1080/1120009x.1994.11736493.
5
Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.卡他布兰汉菌:抗生素敏感性与β-内酰胺酶
J Antimicrob Chemother. 1984 Jan;13(1):55-64. doi: 10.1093/jac/13.1.55.
6
Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.
Drugs. 1986;31 Suppl 3:23-7. doi: 10.2165/00003495-198600313-00007.
7
Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
Drugs. 1986;31 Suppl 3:113-4. doi: 10.2165/00003495-198600313-00024.
8
Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Chemotherapy. 1988;34(4):318-25. doi: 10.1159/000238586.
9
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.棒酸对革兰氏阴性菌β-内酰胺酶的抑制作用。
Biochem J. 1981 Dec 1;199(3):779-87. doi: 10.1042/bj1990779.
10
Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.卡他布兰汉菌β-内酰胺酶与其他细菌产生的青霉素酶的分类关系。
Drugs. 1986;31 Suppl 3:40-7. doi: 10.2165/00003495-198600313-00011.

引用本文的文献

1
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.卡他莫拉菌:临床意义、抗菌药物敏感性及 BRO β-内酰胺酶
Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):219-34. doi: 10.1007/BF01699978.
2
Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays.采用六种不同的β-内酰胺酶检测方法检测卡他莫拉菌临床分离株中的β-内酰胺酶活性。
J Clin Microbiol. 1987 Aug;25(8):1380-3. doi: 10.1128/jcm.25.8.1380-1383.1987.
3
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

本文引用的文献

1
Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.由产β-内酰胺酶的生物体引起的呼吸道感染,用奥格门汀治疗。
Scott Med J. 1982;27 Spec No.:S24-7. doi: 10.1177/00369330820270S106.
2
beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.卡他莫拉菌的β-内酰胺酶及其被克拉维酸的抑制作用
Antimicrob Agents Chemother. 1982 Mar;21(3):506-8. doi: 10.1128/AAC.21.3.506.
3
Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.卡他布兰汉菌:抗生素敏感性与β-内酰胺酶
流感嗜血杆菌、卡他布兰汉菌和淋病奈瑟菌的药敏试验。
Antimicrob Agents Chemother. 1988 Dec;32(12):1747-53. doi: 10.1128/AAC.32.12.1747.
4
In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods.39种抗菌药物对卡他布兰汉菌的体外活性及不同定量药敏试验方法结果的比较
Antimicrob Agents Chemother. 1988 Feb;32(2):259-61. doi: 10.1128/AAC.32.2.259.
5
Branhamella catarrhalis: an organism gaining respect as a pathogen.卡他布兰汉菌:一种日益受到重视的病原菌。
Clin Microbiol Rev. 1990 Oct;3(4):293-320. doi: 10.1128/CMR.3.4.293.
6
Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.产BRO-1和BRO-2的卡他莫拉菌(布兰汉菌属)及非液化莫拉菌菌株中细胞结合型木瓜蛋白酶可溶性β-内酰胺酶的特性分析
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):313-21. doi: 10.1007/BF01962070.
J Antimicrob Chemother. 1984 Jan;13(1):55-64. doi: 10.1093/jac/13.1.55.
4
The origin and properties of beta-lactamase satellite bands seen in isoelectric focusing.在等电聚焦中观察到的β-内酰胺酶卫星条带的起源和特性。
J Antimicrob Chemother. 1983 Aug;12(2):127-31. doi: 10.1093/jac/12.2.127.
5
Porin channels in Escherichia coli: studies with beta-lactams in intact cells.大肠杆菌中的孔蛋白通道:在完整细胞中使用β-内酰胺类药物的研究
J Bacteriol. 1983 Jan;153(1):232-40. doi: 10.1128/jb.153.1.232-240.1983.
6
Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).
Biochim Biophys Acta. 1980 Feb 14;611(2):351-7. doi: 10.1016/0005-2744(80)90071-6.
7
Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity.卡他布兰汉菌中质粒介导的β-内酰胺酶的特性,特别涉及底物亲和力。
J Antimicrob Chemother. 1985 Feb;15(2):139-49. doi: 10.1093/jac/15.2.139.
8
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.克拉维酸:一种来自棒状链霉菌的β-内酰胺酶抑制性β-内酰胺类抗生素。
Antimicrob Agents Chemother. 1977 May;11(5):852-7. doi: 10.1128/AAC.11.5.852.
9
Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.橄榄酸,一类由链霉菌属产生的具有β-内酰胺酶抑制特性的β-内酰胺抗生素。II. 从橄榄色链霉菌中分离和鉴定橄榄酸MM 4550、MM 13902和MM 17880
J Antibiot (Tokyo). 1979 Apr;32(4):295-304. doi: 10.7164/antibiotics.32.295.
10
Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.棒酸对大肠杆菌RTEMβ-内酰胺酶灭活作用的动力学研究
Biochemistry. 1978 May 30;17(11):2180-4. doi: 10.1021/bi00604a024.